Added to YB: 2025-03-05
Pitch date: 2025-03-04
CAPR [bullish]
Capricor Therapeutics, Inc.
+87.19%
current return
Author Info
Biotenic is a freelance L/S biotech investment analyst sharing investment theses. Sign up for the newsletter.
Company Info
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.
Market Cap
$212.1M
Pitch Price
$13.90
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.56
P/E
-2.57
EV/Sales
11.51
Sector
Biotechnology
Category
special_situation
Things that hopefully won't go down 10% every day - $CAPR
CAPR (put sale): Catalyst trade on FDA acceptance of application. March $5 puts at $0.50. Similar filings accepted recently. CEO Marks staying. CMRX up 10% on acceptance as comp. Uncertain timeline and stock volatility. Put sale strategy preferred due to challenges.
Read full article (1 min)